Ms. Shivani Jani | Pharmaceutical Analysis | Best Researcher Award
Smt S M Shah Pharmacy College, India
Author Profile
🎓 Early Academic Pursuits
Ms. Jani’s academic journey began with a strong foundation in pharmaceutical sciences. She completed her Bachelor of Pharmacy (B.Pharm) from B.K. Mody Government Pharmacy College, Rajkot, under Gujarat Technological University (GTU) in 2017, securing a CPI of 7.63. Pursuing her passion for quality assurance, she obtained her Master of Pharmacy (M.Pharm) in Pharmaceutical Quality Assurance from the same institution in 2019, achieving a CPI of 8.06. Her academic excellence is further demonstrated by her impressive scores in higher secondary (92.67%) and secondary education (91.67%).
Currently, Ms. Jani is pursuing her Ph.D. in Pharmaceutical Sciences at Sankalchand Patel University, Visnagar. Her doctoral research focuses on “Analytical Method Development and Validation of Therapeutically Useful Combination of Drugs,” under the guidance of Dr. Ujashkumar Shah, Dean of Research and Innovation. This research underscores her dedication to enhancing analytical methodologies in pharmaceutical sciences.
💼 Professional Endeavors
Ms. Jani’s professional experience encompasses both industry and academia. She began her career in the pharmaceutical industry, working as a Quality Control Assistant at Mifamed Medical Pvt. Ltd., Ahmedabad, from July to December 2019. During her M.Pharm studies, she undertook training and project work in the Regulatory Affairs Department of Corona Remedies Pvt. Ltd., Ahmedabad, and in the Quality Assurance-Quality Control Department of Mifamed Medical Pvt. Ltd. Additionally, she completed a one-month training at Corona Remedies Pvt. Ltd. after her B.Pharm.
In academia, Ms. Jani has been serving as an Assistant Professor at Smt. S. M. Shah Pharmacy College since January 2020. With over three years of teaching experience, she has guided several M.Pharm projects, demonstrating her commitment to mentoring future pharmaceutical professionals.
🧪 Contributions and Research Focus
Ms. Jani’s research interests lie in Quality Assurance and Regulatory Affairs. Her M.Pharm research project, titled “Study of Regulatory Requirements for Pharmaceuticals in Non-European Union States like Kosovo, Ukraine, and Serbia,” reflects her focus on global regulatory frameworks.
She has contributed to several publications in national and international journals, including:
-
“Comparison of Regulatory Requirements for Pharmaceuticals in Non-European Union Member States Kosovo, Ukraine, and Serbia,” published in Applied Clinical Research, Clinical Trials and Regulatory Affairs (2020).
-
“Quantitative Computation of Synthetic Mixture Comprising Sitagliptin and Dapagliflozin from Synthetic Mixture by Vierdot’s Method,” in the Journal of Pharmaceutical Sciences and Drug Discovery (2021).
-
“Quantitative Estimation of Sitagliptin and Dapagliflozin Propanediol Monohydrate in Synthetic Mixture Using 1st Order Derivative Spectroscopy,” in the International Journal of Pharmaceutical Chemistry and Analysis (2022).
-
“Novel Approaches in Green Extraction for Natural Medicines,” in Bioequivalence & Bioavailability International Journal (2022).
-
“Advancing Healthcare: The Imperative Role of Clinical Pharmacokinetics,” an editorial in Acta Scientific Pharmaceutical Sciences (2024).
These publications highlight her expertise in analytical method development, regulatory affairs, and green extraction techniques.Medwin Publishers
🏆 Accolades and Recognition
Ms. Jani’s contributions to pharmaceutical sciences have been recognized through her inclusion in editorial and review boards of reputed journals. She serves on the review board of Acta Scientific Pharmaceutical Sciences, contributing her expertise to the peer-review process. Her active participation in conferences and seminars further underscores her commitment to continuous learning and professional development.
🌟 Impact and Influence
Through her dual roles in industry and academia, Ms. Jani bridges the gap between practical pharmaceutical applications and academic research. Her work in regulatory affairs provides valuable insights into international pharmaceutical standards, benefiting both students and professionals. By guiding M.Pharm projects and engaging in research, she fosters a culture of inquiry and innovation among her students.
🔮 Legacy and Future Contributions
Ms. Jani’s ongoing Ph.D. research positions her to make significant contributions to analytical method development in pharmaceutical sciences. Her dedication to quality assurance and regulatory affairs will continue to influence best practices in the industry. As an educator, she aims to instill a strong foundation of knowledge and ethical practices in her students, preparing them to meet the evolving challenges of the pharmaceutical field.
In summary, Ms. Shivani N. Jani exemplifies the qualities of a dedicated educator and researcher, with a clear vision for advancing pharmaceutical sciences through rigorous research, effective teaching, and active engagement with the professional community.
Notable Publications
-
-
Title: Quantitative estimation of sitagliptin and dapagliflozin propanediol monohydrate in synthetic mixture using 1st order derivative spectroscopy simultaneous spectrophotometric
Authors: S. Jani, R. Shukla, P. Patel, B. Mehta, K. Detholia
Journal: International Journal of Pharmaceutical Chemistry and Analysis
Year: 2022 -
Title: Regulatory Perspective: Human‐Machine Interfaces
Authors: A. Patel, R. Patel, R. Patel, B. Prajapati, S. Jani
Journal: Human‐Machine Interface: Making Healthcare Digital
Year: 2023 -
Title: Clinical Management of Renal Diseases
Authors: S. Jani, H. Katariya, B. Prajapati
Journal: Current Trends in the Diagnosis and Management of Metabolic Disorders
Year: 2023 -
Title: Development of a Quality by Design Based Eco-Friendly RP-HPLC Method for Ticagrelor and Aspirin
Authors: S. Jani, U. Shah, J. Patel, M. Dua
Journal: Green Analytical Chemistry
Year: 2025 -
Title: Regulatory Considerations for Cancer Vaccines Development
Authors: S.N. Jani, H.B. Katariya, B.G. Prajapati
Journal: Cancer Vaccination and Challenges
Year: 2024
-